AI Science Tracker
EN

Medical Artificial Intelligence (AI) Research Center, Research Institute for Future Medicine, Samsung Medical Center, Republic of Korea

1 discovery from 2026

Discoveries

Artificial intelligence-based decision support for axial spondyloarthritis integrating inflammatory and structural MRI information.

Source check: Source checked. Not independent scientific confirmation.

Finding: 302 screened, 291 retained (163 axSpA, 128 controls), SIJ MRI, treating-rheumatologist diagnosis; Results: learned imaging/clinical decision-support evaluated retrospectively. No external or prospective clinical impact established.

Technology: AI decision support links MRI features to clinical diagnosis; retrospective single-center evaluation

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
AI decision support links MRI features to clinical diagnosis; retrospective single-center evaluation.
Test and result
302 screened, 291 retained (163 axSpA, 128 controls), SIJ MRI, treating-rheumatologist diagnosis; Results: learned imaging/clinical decision-support evaluated retrospectively. No external or prospective clinical impact established. Evaluation: Methods: 302 screened, 291 retained (163 axSpA, 128 controls), SIJ MRI, treating-rheumatologist diagnosis; Results: learned imaging/clinical decision-support evaluated retrospectively.
Limitation / still unknown
This is a retrospective single-center evaluation; external validation and prospective clinical impact were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1950510/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.